Mitchell S. Cairo, M.D.
Professor of Pediatrics, Medicine, Pathology, Microbiology and Immunology and Cell Biology and Anatomy & Associate Chairman of the Department of Pediatrics | New York Medical College
Valhalla, NY, UNITED STATES
Dr. Cairo's work focuses on cancer genetics, tumor immunology, transplantation biology, stem cell biology and regenerative medicine.
Media
Publications:
Documents:
Videos:
Audio/Podcasts:
Biography
NYMC physician-researcher Mitchell S. Cairo, M.D., is professor of pediatrics, medicine, pathology, microbiology and immunology and cell biology and anatomy, and associate chairman of the Department of Pediatrics. He is also chief of pediatric hematology, oncology and stem cell transplantation and director of the Children and Adolescent Cancer and Blood Diseases Center at Maria Fareri Children’s Hospital at Westchester Medical Center. His work focuses on cancer genetics, tumor immunology, transplantation biology, stem cell biology and regenerative medicine. He is a graduate of the University of Wisconsin and University of California, San Francisco where he completed his pediatrics residency and he completed a pediatric hematology/oncology fellowship at Indiana University.
Industry Expertise (3)
Health and Wellness
Research
Education/Learning
Areas of Expertise (10)
Genetics and Targeted Therapy in Childhood
Adolescent and Adult Hematological Malignancies
Novel Immunotherapeutic Approaches to Pediatric Cancer
Targeted Cellular Immunotherapy Strategies in Pediatric and Adult Cancers
Stem Cell Biology
Regenerative Therapy
The Use of Alternative Allogeneic Stem Cells for Allogeneic Stem Cell Transplants in Children
Novel Targeted Therapies in Childhood
Adolescent and Young Adult Cancers
Reduced Intensity/Toxicity Conditioning and Allogeneic Stem Cell Transplant in Childhood and Adult Malignant and Non-malignant Diseases
Education (3)
Indiana University: Fellowship, Pediatric Hematology / Oncology
University of California, San Francisco: Residency, Pediatrics
University of California, San Francisco: M.D., Medicine
Media Appearances (10)
Cancer Care Wars Ramp up in Lower Hudson Valley
The Journal News online
2016-11-30
Cairo noted hospitals, though highly competitive financially, generally share findings of medical research, such as his work on using stem-cell and immune therapy in cancer care. "This is a benefit for everyone in the Hudson Valley and we suspect patients will come here from around the world," Cairo said.
Pediatric Cancer Researcher Talks Increasing Survival Rates, Decreased Funding
AMSNY online
2016-11-15
I lead a combination of basic science, translational, and clinical research investigations in the areas of oncology, stem cell transplants, and hematology at New York Medical College and Westchester Medical Center.
SJU players use hoops skills for worthy cause
Times Ledger online
2016-10-01
Dribble for the Cure funds the research of Dr. Mitchell Cairo whose work over the last few years has raised survival rates in certain types of childhood cancers from 20 percent to more than 60 percent.
St. John's Hosts Sixth Annual Dribble for the Cure
The Queens Times online
2016-09-29
Dribble for the Cure primarily funds the research of Dr. Mitchell Cairo, whose work has helped raise survival rates in certain types of childhood cancers from just over 20 percent to more than 60 percent
10 Parenting Debates to Hash Out Before Baby
Parents.com online
2016-06-11
Mitchell S. Cairo, M.D., Chief of Pediatric Hematology, Oncology and Stem Cell Transplantation at Maria Fareri Children's Hospital at Westchester Medical Center, says that there are two types of banking: private directed donor banking and public banking. With private banking, "the cord blood is processed and stored frozen to be only used by the donor or family member at the family's discretion," Dr. Cairo explains.
Dribble for the Cure raises record-breaking $100k
The Torch online
2015-09-30
In unity with University Service Day, the Dribble for the Cure fundraiser increased to over $255,000, since it was first held on campus in 2011. The event continues to give back to Dr. Mitchell S. Cairo, chief of Pediatric Hematology at New York Medical College, which focuses on improving patients’ long term quality of life and the survival rate of children battling cancer. Dr. Cairo was also pleased to announce that the survival rate of children affected by cancer has risen from 20% to over 80% since PCRF was established in 1982...
Pediatric Cancer Research Foundation Shines Light for “Never Quit” Campaign
Queens Times print
2015-07-09
As part of the Never Quit (NVRQT) Campaign to end children’s cancer, the Pediatric Cancer Research Foundation (PCRF) held a special baseball signing at Citi field last Tuesday for pediatric cancer patients from the Maria Fareri Children’s Hospital.
Daughter gone, but never forgotten
Lohud online
2015-05-15
Most of the donations go to the Pediatric Cancer Research Foundation, which provides grants to trailblazing physicians like Dr. Mitchell Cairo, who is now chief of pediatric hematology/oncology and stem cell transplantation at New York Medical College in Valhalla and director of the Children's and Adolescent Blood Disease and Cancer Center at Westchester Medical Center. There, Cairo conducts research in relatively new types of cancer treatments, such as targeted cell therapy...
The Future Lies in Alternative Cancer Therapies
LoHud.com
2015-05-14
Every October, Dr. Mitchell Cairo is reminded why he continues to battle childhood cancer. That's when he gets an email from a former patient, who was diagnosed with acute myeloid leukemia at 16. It's an annual thank-you note, one that marks the anniversary of a life-saving bone marrow transplant that Cairo performed in 1987. Today, that patient is happily married, with three teenagers of his own.
Daughter Gone, But Never Forgotten
LoHud.com
2015-05-14
Haverstraw's David Goldwasser used to call his only child, Marisa, a miracle baby. His wife, Sharon, finally got pregnant after several miscarriages, and when Marisa was born, she was six weeks premature. Despite their early worries, she grew up to be a varsity athlete and a stellar student, topped with a sunny disposition.
Articles (selected) (5)
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
Journal of Clinical Oncology
2008 PURPOSE: Tumor lysis syndrome (TLS) has recently been subclassified into either laboratory TLS or clinical TLS, and a grading system has been established. Standardized guidelines, however, are needed to aid in the stratification of patients according to risk and to establish prophylaxis and treatment recommendations for patients at risk or with established TLS...
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome
Blood
2004 ABSTRACT: Bone marrow transplantation (BMT) can cure myelodysplastic syndrome (MDS), although transplantation carries significant risks of morbidity and mortality. Because the optimal timing of HLA-matched BMT for MDS is unknown, we constructed a Markov model to examine 3 transplantation strategies for newly diagnosed MDS: transplantation at diagnosis, transplantation at leukemic progression, and transplantation at an interval from diagnosis but prior to leukemic progression...
Tumour lysis syndrome: new therapeutic strategies and classification
British Journal of Haematology
2004 SUMMARY: Tumour lysis syndrome (TLS) describes the metabolic derangements that occur with tumour breakdown following the initiation of cytotoxic therapy. TLS results from the rapid destruction of malignant cells and the abrupt release of intracellular ions, nucleic acids ...
Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation
Blood
1997 ABSTRACT: HLA-Matched related allogeneic stem cell transplantation has been successfully used as the treatment of choice in selected high-risk or recurrent hematologic malignancies, marrow failure syndromes, severe congenital immunodeficiency states, and selected metabolic disorders...
Impaired Neutrophil Function in Patients With AIDS or AIDS-Related Complex: A Comprehensive Evaluation
The Journal of Infectious Diseases
1988 ABSTRACT: We measured the neutrophil function of 6 patients with AIDS and Kaposi's sarcoma (KS); 22 patients with AIDS-related complex (ARC); and 28 healthy, heterosexual controls. .Neutrophils from patients with ARC showed significantly less chemotaxis (P ⩽ .025) than did those from patients with AIDS and KS or from controls...